News | Artificial Intelligence | January 28, 2020

Definitive Healthcare Releases Results of AI Use in Imaging Survey

Imaging center leaders and radiologists identify benefits, challenges and areas of use associated with artificial intelligence usage in healthcare

Imaging center leaders and radiologists identify benefits, challenges and areas of use associated with artificial intelligence usage in healthcare

Image by Gerd Altmann from Pixabay 

January 28, 2020 — Definitive Healthcare, a provider of data, intelligence and analytics on healthcare organizations and practitioners, released results from its 2019 AI Use in Imaging Survey. In this survey, Definitive Healthcare polled imaging center leaders and radiologists at U.S.-based acute hospitals and imaging centers from October to December 2019 to determine the adoption rate, primary areas of use, and greatest challenges related to AI usage in imaging.

“Definitive Healthcare’s 2019 Artificial Intelligence Use in Imaging Study shows that one-third of responding organizations are currently utilizing AI technologies in relation to patient care imaging. The widespread interest in these technologies, successful use cases, and continued research and development will likely result in rapid growth and implementation for AI [in relation to imaging] in the near future — particularly as these technologies become more widely-accessible over the next few years,” said Jason Krantz, CEO of Definitive Healthcare.

Definitive Healthcare's market-leading data and analytics platform tracks more than 15,800 imaging centers throughout the U.S., allowing users to find RFPs for imaging equipment, identify key executive contact information, analyze radiology procedures, and review affiliations and relationships with other facilities. Currently, Definitive Healthcare serves 9 out of the top 10 pharmaceutical companies, 9 out of the top 10 healthcare information technology firms, and 8 out of the top 10 medical device companies. In January 2020, Definitive Healthcare announced the acquisition of PatientFinder, which helps clients build highly customized cohorts of patients by analyzing their diagnosis and treatment and identify the physicians and facilities who provide care to those patient populations.

Here are the study’s results:

Current Areas of AI Use in Hospitals and Imaging Centers

  • Computer-aided image detection for disease states (93%)
  • Process or workflow improvement (27%)
  • Technological monitoring (equipment maintenance) (16%)
  • Computer-aided image detection for fractures/musculoskeletal injuries (15%)
  • Care guideline consultation/suggestive care options (13%)
  • Financial or revenue-related performance assistance (13%)

Barriers Associated with AI Implementation in Hospitals and Imaging Centers

  • Cost (55%)
  • Lack of strategic direction (35%)
  • Lack of technical expertise (IT personnel, data scientists) (33%)
  • Lack of necessary IT infrastructure (32%)
  • Regulatory guidelines (26%)
  • Lack of clinical expertise (22%)
  • Lack of leadership buy-in (19%)
  • Current use cases are too narrow (18%)
  • Cybersecurity concerns (16%)

Greatest Benefits of AI in Improving Patient Care

  • Improve or assist in accuracy of diagnosis (57%)
  • Operational improvements (e.g. workflow, access of records, efficiency) (18%)
  • Improve time of diagnosis/early detection (15%)
  • Specific improvement to existing technologies (e.g. CT, MRI, mammograms) (9%)
  • Reduced costs (1%)

For in-depth analysis and visuals related to this survey, view Definitive Healthcare’s related survey blog post here.

For more information: www.definitivehc.com

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 U.S. Surgeon General Jerome Adams, M.D., M.Ph demonstrates how the general public can make their own face masks for non-clinical use.

U.S. Surgeon General Jerome Adams, M.D., M.Ph. demonstrates how the general public can make their own face masks for non-clinical use.

News | Coronavirus (COVID-19) | April 04, 2020 | By Melinda Taschetta-Millane
April 4, 2020 — The Centers for Disease Control and Prevention (CDC)
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im
Jeannie Danker, M.D. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Jeannie Danker, M.D. Photo courtesy of The Ohio State University Wexner Medical Center

News | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane
April 3, 2020 — The radiology world has lost a dedicated leader due to...
An estimated 44 million people worldwide are currently living with Alzheimer’s disease, the most common form of dementia. About 5.8 million people in the United States live with the disease, where it is the sixth leading cause of death overall. While there is not yet a cure for Alzheimer’s, researchers are working to find treatment options to delay its onset and prevent it from developing.

Image courtesy of Insightec

Feature | Ultrasound Imaging | April 02, 2020 | By Katie Caron
An estimated 44 million people worldwide are currently living with...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

News | Ultrasound Imaging | April 02, 2020
April 2, 2020 — Esaote, an Italian company among the world leader